Latest Period
Q1 2026
Security Snapshot
HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB) Institutional Ownership
CUSIP: 40423R204
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
14
Shares (Excl. Options)
449,847
Price
$0.36
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- HCWB on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 449,847
- Total 13F value
- $160,832
- Portfolio coverage rank
- 0%
- Share change
- +14,413
- Value change
- -$220,650
- Number of holders
- 14
- Shares outstanding
- 7,087,776
- SEC-reported price per share
- $0.32
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- HCWB - HCW Biologics Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 40423R204.
- 14 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 14 to 14 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $424,098 to $160,832.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 14 institutions filings for Q1 2026.
Security key
40423R204
Latest holder period
Q1 2026
13F holders
14
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
HCWB full holder history
HCW Biologics Inc. SEC filings
HCW Biologics Inc. company facts
HCW Biologics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 40423R204:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
HCWB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Wong Hing C | 23% | $5,044,206 | 501,911 | Hing C. Wong, Ph.D. | 15 May 2025 | |||
| ARMISTICE CAPITAL, LLC | 5% | -50% | $116,714 | -$15,601 | 353,680 | -12% | Armistice Capital, LLC | 31 Mar 2026 |
As of 31 Mar 2026, 14 institutional investors reported holding 449,847 shares of HCW Biologics Inc. - Common Stock, par value $0.0001 per share (HCWB). This represents 6.3% of the company’s total 7,087,776 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4